ID

30096

Descripción

A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00988221

Link

https://clinicaltrials.gov/show/NCT00988221

Palabras clave

Versiones (1)
  1. 9/5/18 9/5/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

9 de mayo de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Juvenile Idiopathic Arthritis NCT00988221

Inglés

Eligibility Juvenile Idiopathic Arthritis NCT00988221

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
children/juveniles, 2-17 years of age.
Descripción

Children | Juvenile | Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0008059
UMLS CUI [2]
C3146221
UMLS CUI [3]
C0001779
polyarticular-course juvenile idiopathic arthritis (pcjia) ≥ 6 months duration.
Descripción

Juvenile arthritis Course Polyarticular Duration

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3495559
UMLS CUI [1,2]
C0750729
UMLS CUI [1,3]
C0240789
UMLS CUI [1,4]
C0449238
active disease (≥ 5 active joints, ≥ 3 with limitation of motion).
Descripción

Disease Active | Active joint count | Joints Quantity Limitation of motion

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205177
UMLS CUI [2]
C4067216
UMLS CUI [3,1]
C0022417
UMLS CUI [3,2]
C1265611
UMLS CUI [3,3]
C0231589
inadequate response to or inability to tolerate methotrexate.
Descripción

Methotrexate Disease Response Inadequate | Intolerance to Methotrexate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C1704632
UMLS CUI [1,3]
C0205412
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C0025677
methotrexate, oral corticosteroids, and non-steroidal anti-inflammatory drugs (nsaid) at stable dose(at least 8, 4, and 2 weeks,respectively) prior to baseline.
Descripción

Methotrexate Dose Stable | Adrenal Cortex Hormones Oral Dose Stable | NSAIDs Dose Stable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2,1]
C0001617
UMLS CUI [2,2]
C1527415
UMLS CUI [2,3]
C0178602
UMLS CUI [2,4]
C0205360
UMLS CUI [3,1]
C0003211
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205360
biologics discontinued, between at least 1 and 20 weeks prior to baseline, depending on biologic.
Descripción

Biological agents Discontinued

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005515
UMLS CUI [1,2]
C1444662
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
auto-immune, rheumatic disease or overlap syndrome other than pcjia.
Descripción

Autoimmune Diseases | Rheumatism | Overlap syndrome | Exception Juvenile arthritis Course Polyarticular

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004364
UMLS CUI [2]
C0035435
UMLS CUI [3]
C0410000
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C3495559
UMLS CUI [4,3]
C0750729
UMLS CUI [4,4]
C0240789
wheelchair bound or bedridden.
Descripción

Wheelchair bound | Bed-ridden

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0558195
UMLS CUI [2]
C0425251
intra-articular, intramuscular, intravenous, or long-acting corticosteroids within 4 weeks prior to baseline.
Descripción

Adrenal Cortex Hormones Intraarticular | Adrenal Cortex Hormones Intramuscular | Adrenal Cortex Hormones Intravenous | Adrenal Cortex Hormones Active Long-term

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C1522204
UMLS CUI [2,1]
C0001617
UMLS CUI [2,2]
C1556154
UMLS CUI [3,1]
C0001617
UMLS CUI [3,2]
C1522726
UMLS CUI [4,1]
C0001617
UMLS CUI [4,2]
C0205177
UMLS CUI [4,3]
C0443252
disease-modifying anti-rheumatic drugs (dmard) (other than methotrexate) within 4 weeks prior to baseline.
Descripción

Antirheumatic Drugs, Disease-Modifying | Exception Methotrexate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0242708
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0025677
previous treatment with tocilizumab.
Descripción

tocilizumab

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1609165
Volver a la parte superior de la página

Similar models

Eligibility Juvenile Idiopathic Arthritis NCT00988221

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Children | Juvenile | Age
Item
children/juveniles, 2-17 years of age.
boolean
C0008059 (UMLS CUI [1])
C3146221 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
Juvenile arthritis Course Polyarticular Duration
Item
polyarticular-course juvenile idiopathic arthritis (pcjia) ≥ 6 months duration.
boolean
C3495559 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
C0240789 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,4])
Disease Active | Active joint count | Joints Quantity Limitation of motion
Item
active disease (≥ 5 active joints, ≥ 3 with limitation of motion).
boolean
C0012634 (UMLS CUI [1,1])
C0205177 (UMLS CUI [1,2])
C4067216 (UMLS CUI [2])
C0022417 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0231589 (UMLS CUI [3,3])
Methotrexate Disease Response Inadequate | Intolerance to Methotrexate
Item
inadequate response to or inability to tolerate methotrexate.
boolean
C0025677 (UMLS CUI [1,1])
C1704632 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
C1744706 (UMLS CUI [2,1])
C0025677 (UMLS CUI [2,2])
Methotrexate Dose Stable | Adrenal Cortex Hormones Oral Dose Stable | NSAIDs Dose Stable
Item
methotrexate, oral corticosteroids, and non-steroidal anti-inflammatory drugs (nsaid) at stable dose(at least 8, 4, and 2 weeks,respectively) prior to baseline.
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0001617 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,3])
C0205360 (UMLS CUI [2,4])
C0003211 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
Biological agents Discontinued
Item
biologics discontinued, between at least 1 and 20 weeks prior to baseline, depending on biologic.
boolean
C0005515 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Autoimmune Diseases | Rheumatism | Overlap syndrome | Exception Juvenile arthritis Course Polyarticular
Item
auto-immune, rheumatic disease or overlap syndrome other than pcjia.
boolean
C0004364 (UMLS CUI [1])
C0035435 (UMLS CUI [2])
C0410000 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C3495559 (UMLS CUI [4,2])
C0750729 (UMLS CUI [4,3])
C0240789 (UMLS CUI [4,4])
Wheelchair bound | Bed-ridden
Item
wheelchair bound or bedridden.
boolean
C0558195 (UMLS CUI [1])
C0425251 (UMLS CUI [2])
Adrenal Cortex Hormones Intraarticular | Adrenal Cortex Hormones Intramuscular | Adrenal Cortex Hormones Intravenous | Adrenal Cortex Hormones Active Long-term
Item
intra-articular, intramuscular, intravenous, or long-acting corticosteroids within 4 weeks prior to baseline.
boolean
C0001617 (UMLS CUI [1,1])
C1522204 (UMLS CUI [1,2])
C0001617 (UMLS CUI [2,1])
C1556154 (UMLS CUI [2,2])
C0001617 (UMLS CUI [3,1])
C1522726 (UMLS CUI [3,2])
C0001617 (UMLS CUI [4,1])
C0205177 (UMLS CUI [4,2])
C0443252 (UMLS CUI [4,3])
Antirheumatic Drugs, Disease-Modifying | Exception Methotrexate
Item
disease-modifying anti-rheumatic drugs (dmard) (other than methotrexate) within 4 weeks prior to baseline.
boolean
C0242708 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0025677 (UMLS CUI [2,2])
tocilizumab
Item
previous treatment with tocilizumab.
boolean
C1609165 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial